Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Capital Employed (2019 - 2026)

Health Catalyst filings provide 8 years of Return on Capital Employed readings, the most recent being 70.66% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 5812.0% to 70.66% in Q1 2026 year-over-year; TTM through Mar 2026 was 70.66%, a 5812.0% decrease, with the full-year FY2025 number at 27.21%, down 1185.0% from a year prior.
  • Return on Capital Employed hit 70.66% in Q1 2026 for Health Catalyst, down from 35.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 12.54% in Q1 2025 to a low of 70.66% in Q1 2026.
  • Median Return on Capital Employed over the past 5 years was 20.52% (2023), compared with a mean of 23.34%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 1822bps in 2022 and later crashed -5812bps in 2026.
  • Health Catalyst's Return on Capital Employed stood at 20.54% in 2022, then grew by 0bps to 20.52% in 2023, then surged by 33bps to 13.68% in 2024, then plummeted by -158bps to 35.33% in 2025, then tumbled by -100bps to 70.66% in 2026.
  • The last three reported values for Return on Capital Employed were 70.66% (Q1 2026), 35.33% (Q4 2025), and 17.96% (Q3 2025) per Business Quant data.